| 4T1 | Mouse mammary carcinoma cell line |
| AKT | Protein Kinase B |
| ALOX12/15 | Arachidonate 12/15-Lipoxygenase |
| AR | Androgen Receptor |
| AuNPs | Gold Nanoparticles |
| Bax | Bcl-2-Associated X Protein |
| BBB | Blood-Brain Barrier |
| Bcl-2 | B-Cell Lymphoma 2 |
| BCT | Breast-Conserving Therapy |
| CCID | Cell Cycle Inhibitory Dose |
| CDK4/6 | Cyclin-Dependent Kinase 4/6 |
| COX-2 | Cyclooxygenase-2 |
| CSC | Cancer Stem Cells |
| CYP1 | Cytochrome P450 Family 1 |
| CYP1B1 | Cytochrome P450 Family 1 Subfamily B Member 1 |
| DDIT4 | DNA Damage-Inducible Transcript 4 |
| Drp1 | Dynamin-Related Protein 1 |
| E2 | Estradiol |
| EGCG | Epigallocatechin Gallate |
| EMT | Epithelial-Mesenchymal Transition |
| ER | Estrogen Receptor |
| ERK | Extracellular Signal-Regulated Kinase |
| ERα | Estrogen Receptor Alpha |
| FAK | Focal Adhesion Kinase |
| GI Absorption | Gastrointestinal Absorption |
| GLOBOCAN | Global Cancer Observatory |
| GPR30 | G Protein-Coupled Estrogen Receptor 30 |
| H-Bond | Hydrogen Bond |
| HCT-116 | Human Colon Cancer Cell Line |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| HIF-1α | Hypoxia-Inducible Factor 1-Alpha |
| HR+ | Hormone Receptor-Positive |
| HUVECs | Human Umbilical Vein Endothelial Cells |
| IC50 | Half-Maximal Inhibitory Concentration |
| IFIT2 | Interferon-Induced Protein with Tetratricopeptide Repeats 2 |
| IGF-I | Insulin-Like Growth Factor 1 |
| IL-10 | Interleukin 10 |
| IL-6 | Interleukin 6 |
| IORT | Intraoperative Radiotherapy |
| JNK | c-Jun N-Terminal Kinase |
| LDH | Lactate Dehydrogenase |
| Log Kp | Logarithm of Skin Permeation Coefficient |
| LogPo/w | Logarithm of Octanol-Water Partition Coefficient (lipophilicity measure) |
| LogS | Logarithm of Aqueous Solubility |
| LOX-12 | Lipoxygenase-12 |
| MAPK | Mitogen-Activated Protein Kinase |
| MCF-10A | Non-Tumorigenic Breast Epithelial Cell Line |
| MDA-MB-231 | Human Triple-Negative Breast Cancer Cell Line |
| MDA-MB-468 | Human Breast Cancer Cell Line |
| miRNA | MicroRNA |
| MMP | Matrix Metalloproteinase |
| MMTV-PyMT | Mouse Mammary Tumor Virus-Polyoma Middle T Antigen |
| MOFs | Metal-Organic Frameworks |
| mTOR | Mammalian Target of Rapamycin |
| NF-κB | Nuclear Factor Kappa B |
| NLC | Nanostructured Lipid Carrier |
| NOD/SCID | Non-Obese Diabetic/Severe Combined Immunodeficiency |
| P-gp | P-glycoprotein (efflux transporter) |
| PARP | Poly (ADP-Ribose) Polymerase |
| PD-L1 | Programmed Death-Ligand 1 |
| PI3K | Phosphoinositide 3-Kinase |
| PIM-1 | Proto-oncogene serine/threonine-protein kinase |
| PLGA | Polylactic-co-Glycolic Acid |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROCR | Protein C Receptor |
| ROS | Reactive Oxygen Species |
| SATB1 | Special AT-Rich Sequence-Binding Protein 1 |
| SGNI | Shuganning Injection |
| SREBP1 | Sterol Regulatory Element-Binding Protein 1 |
| STAT3 | Signal Transducer and Activator of Transcription 3 |
| TGF-β1 | Transforming Growth Factor Beta 1 |
| TNBC | Triple-Negative Breast Cancer |
| TNF-α | Tumor Necrosis Factor Alpha |
| TPSA | Topological Polar Surface Area |
| u-PA | Urokinase-Type Plasminogen Activator |
| VEGF | Vascular Endothelial Growth Factor |
| ZEB1 | Zinc Finger E-Box Binding Homeobox 1 |
| ZIF-8 | Zeolitic Imidazolate Framework 8 |